- Home
- RVNC vs BKT Comparison
RVNC vs BKT Comparison
Compare RVNC & BKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- BKT
- Stock Information
- Founded
- RVNC 1999
- BKT 1988
- Country
- RVNC United States
- BKT United States
- Employees
- RVNC N/A
- BKT N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- BKT Investment Bankers/Brokers/Service
- Sector
- RVNC Health Care
- BKT Finance
- Exchange
- RVNC Nasdaq
- BKT Nasdaq
- Market Cap
- RVNC 546.4M
- BKT 267.4M
- IPO Year
- RVNC 2014
- BKT N/A
- Fundamental
- Price
- RVNC $5.18
- BKT $12.22
- Analyst Decision
- RVNC Buy
- BKT
- Analyst Count
- RVNC 10
- BKT 0
- Target Price
- RVNC $10.86
- BKT N/A
- AVG Volume (30 Days)
- RVNC 1.9M
- BKT 67.9K
- Earning Date
- RVNC 11-06-2024
- BKT 01-01-0001
- Dividend Yield
- RVNC N/A
- BKT 8.97%
- EPS Growth
- RVNC N/A
- BKT N/A
- EPS
- RVNC N/A
- BKT N/A
- Revenue
- RVNC $251,178,000.00
- BKT N/A
- Revenue This Year
- RVNC $20.36
- BKT N/A
- Revenue Next Year
- RVNC $31.66
- BKT N/A
- P/E Ratio
- RVNC N/A
- BKT N/A
- Revenue Growth
- RVNC 40.23
- BKT N/A
- 52 Week Low
- RVNC $2.30
- BKT $10.55
- 52 Week High
- RVNC $9.75
- BKT $12.92
- Technical
- Relative Strength Index (RSI)
- RVNC 39.04
- BKT 37.21
- Support Level
- RVNC $5.13
- BKT $12.23
- Resistance Level
- RVNC $5.34
- BKT $12.45
- Average True Range (ATR)
- RVNC 0.18
- BKT 0.09
- MACD
- RVNC 0.00
- BKT -0.03
- Stochastic Oscillator
- RVNC 39.53
- BKT 0.00
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About BKT BlackRock Income Trust Inc. (The)
Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65% of its assets in mortgage-backed securities. The Fund invests at least 80% of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings ("S&P") or Aaa by Moody's Investors Service, Inc ("Moody's"). The Fund may invest directly in such securities or synthetically through the use of derivatives.